CPC A61N 1/36031 (2017.08) [A61N 1/025 (2013.01); A61N 1/0456 (2013.01); A61N 1/0476 (2013.01); A61N 1/08 (2013.01); G16H 20/30 (2018.01); G16H 50/20 (2018.01)] | 12 Claims |
1. A wearable neurostimulation device for transcutaneously stimulating one or more peripheral nerves of a user, the device comprising:
one or more electrodes configured to generate electric stimulation signals;
one or more sensors configured to detect motion signals, wherein the one or more sensors are operably connected to the wearable neurostimulation device; and
one or more hardware processors configured to:
receive raw signals relating to device interaction events;
store the device interaction events into a data log;
perform an anomalous sequence detection analysis on entries of the data log;
perform an event sequence classification on entries of the data log;
determine at least one of an anomaly type and/or an anomaly score;
determine anomalous device function patterns or device usage patterns, wherein the anomalous device function patterns relate to determining or predicting a malfunction of the wearable neurostimulation device, and wherein the device usage patterns relate to abnormal usage of the wearable neurostimulation device by the user;
communicate information related to the anomalous device function patterns or the device usage patterns to the user or a third party;
wherein the device is non implantable, and
wherein the anomalous sequence detection analysis comprises utilizing Markov chains.
|